Dx&Vx Presents A New Paradigm For Next-Generation Infectious Disease Response With The Development Of A Universal Vaccine
A Dx&Vx representative stated, "The ultimate goal of the Ferritin platform-based VLP vaccine under development is to provide ...
News Medical on MSN15h
Review highlights the pathogenesis and Clinical Spectrum of Nipah virus infection
Nipah virus (NiV), a zoonotic paramyxovirus with significant human health implications, has garnered considerable attention ...
Vietnam Investment Reviev8d
Dx&Vx, From mRNA Vaccines to Nanoparticle Vaccines era of Next-Generation Vaccines
Breakthrough infections, where individuals contract the disease despite vaccination, became a critical issue as variant ...
infectiousdiseaseadvisor.com7d
FDA Drug Approval Decisions Expected in February 2025
The FDA is reviewing new vaccines for meningitis and chikungunya and therapies for Parkinson disease and PTSD.
News Medical on MSN9d
Decades of research push cytomegalovirus vaccine closer to reality
Researchers review decades of progress in human cytomegalovirus (HCMV) vaccine development, emphasizing challenges, ...
Monthly Prescribing Reference13d
FDA Drug Approval Decisions Expected in February 2025
The FDA granted Priority Review to the BLA for CHIKV VLP, an adjuvanted virus-like particle (VLP)-based vaccine candidate for active immunization to prevent disease caused by chikungunya virus ...
GeoVax Labs, Inc. (NASDAQ:GOVX) Given Consensus Recommendation of “Buy” by Brokerages
Shares of GeoVax Labs, Inc. (NASDAQ:GOVX – Get Free Report) have been assigned an average rating of “Buy” from the seven brokerages that are currently covering the stock, MarketBeat reports. Five ...
NZ research: What scientists are discovering about how our bodies fight infection
Pioneering research led by New Zealand and US scientists suggests that’s not such a far-fetched idea – and it could pave the ...